Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Wolkenstein

Showing results (151-160 of 230) with videos related to

Pageof 23
Sort By:
Journal of Burn Care & Research : Official Publication of the American Burn Association|October 22, 2020
Missed Diagnosis of Epilepsy-Associated Scald Burns: Two Cases Initially Diagnosed as Bullous DermatosisLaura Giraud-Kerleroux, Chloé Charpentier, Charlotte Bernigaud, et al.
Neuro-Oncology|January 14, 2014
mTORC1 inhibition delays growth of neurofibromatosis type 2 schwannomaMarco Giovannini, Nicolas-Xavier Bonne, Jeremie Vitte, et al.
European Journal of Human Genetics : EJHG|July 31, 2014
Neurofibromatosis type 1 molecular diagnosis: what can NGS do for you when you have a large gene with loss of function mutations?Eric Pasmant, Béatrice Parfait, Armelle Luscan, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 14, 2021
Face transplantation: A longitudinal histological study focusing on chronic active and mucosal rejection in a series with long-term follow-upAnissa Moktefi, Mikael Hivelin, Philippe Grimbert, et al.
Plos One|March 18, 2016
Metabolic Tumour Burden Measured by 18F-FDG PET/CT Predicts Malignant Transformation in Patients with Neurofibromatosis Type-1Axel Van Der Gucht, Ouidad Zehou, Soraya Djelbani-Ahmed, et al.
Journal of Dermatological Science|January 16, 2007
A French CDK4-positive melanoma family with a co-inherited EDNRB mutationNadem Soufir, Laurence Ollivaud, Guylene Bertrand, et al.
The Journal of Molecular Diagnostics : JMD|September 22, 2009
Detection and characterization of NF1 microdeletions by custom high resolution array CGHEric Pasmant, Audrey Sabbagh, Julien Masliah-Planchon, et al.
Molecular Medicine (Cambridge, Mass.)|September 17, 2010
Identification of genes potentially involved in the increased risk of malignancy in NF1-microdeleted patientsEric Pasmant, Julien Masliah-Planchon, Pascale Lévy, et al.
The Journal of Investigative Dermatology|June 24, 2023
A Call for Discovery and Therapeutic Development for Cutaneous NeurofibromasJaishri O Blakeley, Lu Q Le, Sang Y Lee, et al.
Journal of Dermatological Science|December 16, 2006
Melanoma susceptibility and progression: Association study between polymorphisms of the chemokine (CCL2) and chemokine receptors (CX3CR1, CCR5)Mathieu Rodero, Pauline Rodero, Vincent Descamps, et al.
Pageof 23

Showing results (151-160 of 230) with videos related to

Sort By:
Pageof 23
Journal of Burn Care & Research : Official Publication of the American Burn Association|October 22, 2020
Missed Diagnosis of Epilepsy-Associated Scald Burns: Two Cases Initially Diagnosed as Bullous DermatosisLaura Giraud-Kerleroux, Chloé Charpentier, Charlotte Bernigaud, et al.
Neuro-Oncology|January 14, 2014
mTORC1 inhibition delays growth of neurofibromatosis type 2 schwannomaMarco Giovannini, Nicolas-Xavier Bonne, Jeremie Vitte, et al.
European Journal of Human Genetics : EJHG|July 31, 2014
Neurofibromatosis type 1 molecular diagnosis: what can NGS do for you when you have a large gene with loss of function mutations?Eric Pasmant, Béatrice Parfait, Armelle Luscan, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 14, 2021
Face transplantation: A longitudinal histological study focusing on chronic active and mucosal rejection in a series with long-term follow-upAnissa Moktefi, Mikael Hivelin, Philippe Grimbert, et al.
Plos One|March 18, 2016
Metabolic Tumour Burden Measured by 18F-FDG PET/CT Predicts Malignant Transformation in Patients with Neurofibromatosis Type-1Axel Van Der Gucht, Ouidad Zehou, Soraya Djelbani-Ahmed, et al.
Journal of Dermatological Science|January 16, 2007
A French CDK4-positive melanoma family with a co-inherited EDNRB mutationNadem Soufir, Laurence Ollivaud, Guylene Bertrand, et al.
The Journal of Molecular Diagnostics : JMD|September 22, 2009
Detection and characterization of NF1 microdeletions by custom high resolution array CGHEric Pasmant, Audrey Sabbagh, Julien Masliah-Planchon, et al.
Molecular Medicine (Cambridge, Mass.)|September 17, 2010
Identification of genes potentially involved in the increased risk of malignancy in NF1-microdeleted patientsEric Pasmant, Julien Masliah-Planchon, Pascale Lévy, et al.
The Journal of Investigative Dermatology|June 24, 2023
A Call for Discovery and Therapeutic Development for Cutaneous NeurofibromasJaishri O Blakeley, Lu Q Le, Sang Y Lee, et al.
Journal of Dermatological Science|December 16, 2006
Melanoma susceptibility and progression: Association study between polymorphisms of the chemokine (CCL2) and chemokine receptors (CX3CR1, CCR5)Mathieu Rodero, Pauline Rodero, Vincent Descamps, et al.
Pageof 23